Skip to content

Clinical trials

Phase 1 Sarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 1 Country / region: United States Clear all

280 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200110
20023
20032
20049
200511
20066
200711
20085
20099
201010
20119
201214
20136
201411
201512
201613
20178
201811
201915
202010
20219
202213
20238
202413
202512
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed144
Terminated55
Recruiting30
Active, not recruiting23
Withdrawn13
Unknown status7
Not yet recruiting4
Suspended3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)32
M.D. Anderson Cancer Center13
Memorial Sloan Kettering Cancer Center8
Fred Hutchinson Cancer Center6
Masonic Cancer Center, University of Minnesota6
Eli Lilly and Company5
National Institutes of Health Clinical Center (CC)5
Pfizer5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
Washington University School of Medicine5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma280
Melanoma57
Breast Neoplasms56
Osteosarcoma47
Ovarian Neoplasms47
Neoplasms45
Carcinoma, Non-Small-Cell Lung41
Neuroblastoma41
Colorectal Neoplasms34
Pancreatic Neoplasms33

Trials

Showing 1 to 25 of 280. Each trial links to its page on Pharma Observatory.

180 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.